Molecular pathogenesis of interstitial cystitis based on microRNA expression signature: miR-320 family-regulated molecular pathways and targets

Expression profile of urothelial transcription factors in bladder biopsies with interstitial cystitis

(2017) Kanya Kaga et al.   INTERNATIONAL JOURNAL OF UROLOGY

p63α protein up-regulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion

(2017) Honglei Jin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA-320 suppresses cervical cancer cell viability, migration and invasion via directly targeting FOXM1

(2017) Can Shi et al.   Oncology Letters

Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs

(2017) Keiichi Koshizuka et al.   Oncotarget

The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster

(2017) Keiichi Yonemori et al.   Oncotarget

MicroRNAs in Allergic Disease

(2016) Eishika Dissanayake et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer

(2016) ATSUSHI OKATO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1

(2016) Radhakrishnan Vishnubalaji et al.   Oncotarget

MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker

(2015) Yusuke Goto et al.   BRITISH JOURNAL OF CANCER

Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer

(2015) R Matsushita et al.   BRITISH JOURNAL OF CANCER

Ablation of the transcription factors E2F1-2 limits neuroinflammation and associated neurological deficits after contusive spinal cord injury

(2015) Junfang Wu et al.   CELL CYCLE

TERTpromoter mutations and telomerase reactivation in urothelial cancer

(2015) Sumit Borah et al.   SCIENCE

Rab23 is overexpressed in human bladder cancer and promotes cancer cell proliferation and invasion

(2015) Yuanjun Jiang et al.   TUMOR BIOLOGY

MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6

(2014) Xiao Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MiR-320a down-regulation mediates bladder carcinoma invasion by targeting ITGB3

(2014) Chao Shang et al.   MOLECULAR BIOLOGY REPORTS

The MicroRNA Expression Signature of Bladder Cancer by Deep Sequencing: The Functional Significance of the miR-195/497 Cluster

(2014) Toshihiko Itesako et al.   PLoS One

miR-320 regulates tumor angiogenesis driven by vascular endothelial cells in oral cancer by silencing neuropilin 1

(2013) Yi-Ying Wu et al.   ANGIOGENESIS

Transcriptional Regulation and Its Misregulation in Disease

(2013) Tong Ihn Lee et al.   CELL

Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes

(2013) Warren A. Whyte et al.   CELL

Super-Enhancers in the Control of Cell Identity and Disease

(2013) Denes Hnisz et al.   CELL

MicroRNAs: Essential players in the regulation of inflammation

(2013) Ana Rebane et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer

(2012) Miki Fuse et al.   JOURNAL OF HUMAN GENETICS

The tubby family proteins

(2011) Saikat Mukhopadhyay et al.   GENOME BIOLOGY

MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease

(2011) Tai-You Ha   Immune Network

MicroRNAs May Mediate the Down-Regulation of Neurokinin-1 Receptor in Chronic Bladder Pain Syndrome

(2009) Veronica Sanchez Freire et al.   AMERICAN JOURNAL OF PATHOLOGY

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH

MicroRNAs and cancer: past, present, and potential future

(2008) K. M. Nelson et al.   MOLECULAR CANCER THERAPEUTICS

Diagnostic Criteria, Classification, and Nomenclature for Painful Bladder Syndrome/Interstitial Cystitis: An ESSIC Proposal

(2007) Joop P. van de Merwe et al.   EUROPEAN UROLOGY